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Overview of Project 
Oxygen availability in tissue engineered substitutes is a critical parameter that 
directly influences a construct's desired function. Previous investigations in our group 
have shown correlations between the function of cells encapsulated in calcium alginate 
beads and the dissolved oxygen (DO) concentration in the surrounding medium. 
However, these experiments measured only the DO upstream and downstream of a 
bioreactor within a perfusion system. To take the previous experiments one step further, 
and to initiate studies towards in vivo monitoring of DO levels in tissue substitutes, we 
utilize Fluorine-19 ( 1 9F) nuclear magnetic resonance (NMR) spectroscopy to monitor the 
oxygen concentration directly available to the cells within calcium alginate-based beads. 
This is accomplished by co-encapsulating a perfluorocarbon (PFC) emulsion with the 
cells. The 1 9 F NMR studies are being performed at the University of Florida in a 500 
MHz, vertical bore magnet. To perform the desired experiments in a controlled fashion, 
a perfusion system capable of maintaining the DO concentration at levels set by the user 
was developed and utilized. The perfusion system maintained temperature control, 
allowed for replenishment of nutrients, and enabled the performance of step changes in 
glucose and DO concentrations, as instructed by the operator. By collecting 1 9 F NMR 
spectra from the beads in the entire bioreactor volume, the average intrabead DO 
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concentrations (AIDOs), both axially over the bioreactor and radially through the alginate 
beads, were obtained. 
The perfusion system was used to carry out controlled experiments with alginate-
encapsulated mouse insulinoma cells, in which the DO concentration in the perfusion 
medium was subjected to prescribed decreases and increases. A mathematical model 
describing the cellular remodeling that occurs within the beads, and the changes in the 
intrabead cellular and DO distributions that occur with time, was developed and used 
synergistically with experiments to obtain additional information on the system at hand. 
This research is significant both fundamentally, in understanding the metabolic and 
secretory functions of the encapsulated system, and practically, in developing the 
necessary technologies for monitoring encapsulated systems non-invasively in vitro and 
in vivo. 
There have been no changes in the Specific Aims of this subcontract. Graduate 
Research Assistant Jeff Gross graduated during last year, and this work is continued by 
Graduate Research Assistant Fernie Goh. 
Work performed during the period 04/2006 to 05/2007 
The work carried out at the Georgia Institute of Technology under this subcontract from 
the University of Florida focuses on developing, characterizing, and implementing the 1 9 F 
NMR methodology to monitor average DO levels in encapsulated cell systems in vitro 
and in small animals in vivo. During the above mentioned period we performed the 
following studies. 
1. We completed the development and validation of a mathematical model of the 
encapsulated cell system that allows estimating the viable cell number and the radial cell 
density and DO concentration gradients from the value of average intrabead dissolved 
oxygen concentration (AIDO), where the latter can be measured experimentally by 1 9F 
NMR. This work was published in Gross, J.D., Constantinidis, I., and Sambanis, A., 
"Modeling of Encapsulated Cell Systems," Journal of Theoretical Biology, 244: 500-510 
(2007). 
2. We performed experiments with alginate-encapsulated mouse insulinoma pTC-tet cells 
placed in the perfusion bioreactor and subjected to step decreases of DO in the medium 
entering the bioreactor (DOin), followed by step increases of DOin to the initial levels. 
During the experiments, AIDO values were otbained by 1 9 F NMR spectroscopy, and 
cellular bioenergetics were evaluated by 3 1 P NMR. The experimentally obtained system 
dynamics were simulated by the mathematical model, and the agreement of the two was 
found to be good, thus providing further credence to the ability of the model to reliably 
predict aspects of the system behavior from a limited set of experimental measurements. 
This work is currently in press in Gross, J.D., Long, R.C., Jr., Constantinidis, I., and 
Sambanis, A., "Monitoring of Dissolved Oxygen and Cellular Bioenergetics within a 
Pancreatic Substitute," Biotechnology and Bioengineering. 
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3. Similar experiments were performed with alginate-encapsulated pTC-tet cells that 
were allowed to grow in the beads prior to being placed in the NMR-compatible 
perfusion bioreactor, and were then subjected to step changes in DOin or to a cytotoxic 
antibiotic. The latter was added to simulate a specific immune response against the 
encapsulated cell system. Results from this study are reported in the manuscript Gross 
JD, Simpson NE, Constantinidis I, and Sambanis A, "Monitoring a Pancreatic Substitute 
During Transient Hypoxia and Cell Death," in preparation. 
3. Additionally, we developed a two PFC system that allows the simultaneous 
measurement of the average DO concentration in two populations of beads. The system 
was validated experimentally by encapsulating one of the PFCs in inflammatory 
alginate/PLL beads and the second PFC in non-inflammatory alginate only beads, 
implanting the two bead populations in the peritoneal cavity of mice, and demonstrating 
that the AIDO concentration in the alginate/PLL beads became lower than that in the 
alginate beads few days post-implantation. This was due to the fibrotic layer that 
developed around the inflammatory beads. This work was performed collaboratively 
with Dr. R.C. Long, Jr., Department of Radiology, Emory University. This methodology 
can be used to evaluate in vivo the biocompatibility of materials and to monitor the AIDO 
in a population of cell-containing beads, while a cell-free bead control is used to monitor 
the DO concentration at the implantation site. Measurements of the latter are significant, 
since the DO at particular in vivo locales can change significantly from animal to animal 
and with conditions, e.g., anesthesia. This work is in press in the same article cited in 
paragraph 2. 
4. Lastly, we are in the process of evaluating experimentally and via mathematical 
modeling the effect of PFCs, if any, on the viability and metabolic and secretory function 
of encapsulated cells. This work will continue into the 2007-8 year of the grant. 
Plans for 2007-8 
For the next year of the subcontract, we plan to: 
1. Continue the work on evaluating the effect of PFCs on encapsulated cells, both 
under normoxic and hypoxic conditions. 
2. Initiating studies towards using the two PFC system to monitor the AIDO in an 
encapsulated cell implant simultaneously with the DO concentration at the implantation 
site. 
3. Finalize and submit the manuscript in preparation described in paragraph 3 of the 
previous section. 
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